Peptide library Metabolic & Weight

Retatrutide

Also known as: Triple incretin agonist

An investigational triple agonist studied across GLP-1, GIP and glucagon pathways for metabolic and weight-management research.

GLP-1
GIP
Glucagon receptor

What it is

Plain-English overview

Retatrutide is an investigational metabolic compound designed to activate three receptor pathways: GLP-1, GIP and glucagon.

Mechanism

How it is thought to work

GLP-1 and GIP influence appetite, satiety and glucose handling. The glucagon arm is studied for possible effects on energy expenditure and fat metabolism.

Studied for

Research interest areas

Weight-management research
Appetite regulation
Glucose and energy-expenditure pathways

Evidence

What the research suggests

Early human trials have drawn attention because of large weight-loss signals. It remains investigational, so long-term safety and broader use are still being defined.

A note on safety. This content is educational and is not medical advice. Many peptides and adjacent compounds are research materials and may not be approved medicines. Speak with a qualified healthcare professional before considering anything discussed here.